AKT1 and cancer: In GC, accumulating studies have provided that AKT/mTOR activation is often observed in clinical specimens as well as in GC cell lines and the phosphorylation level of mTOR is positively correlated with cancer development, chemoresistance, and poor clinical outcome [47, 48].